MURFREESBORO, Tenn., May 09, 2025--(BUSINESS WIRE)--National HealthCare Corporation (NYSE American: NHC), the nation's oldest publicly traded senior health care company, announced today net operating revenues for the quarter ended March 31, 2025 totaled $373,697,000 compared to $297,176,000 for the quarter ended March 31, 2024, an increase of 25.7%. The increase in net operating revenues for the first quarter of 2025 compared to the first quarter of 2024 was due to an 8.5% increase in same-facility net operating revenues, as well as the August 1, 2024 acquisition of White Oak Management, Inc. ("White Oak"). The White Oak operations consist of 22 healthcare operations, which include 15 skilled nursing facilities, two assisted living facilities, four independent living facilities, and a long-term care pharmacy.
For the quarter ended March 31, 2025, the reported GAAP net income attributable to NHC was $32,205,000 compared to $26,213,000 for the same period in 2024. Excluding the unrealized gains in our marketable equity securities portfolio and other non-GAAP adjustments, adjusted net income for the quarter ended March 31, 2025 was $24,838,000 compared to $15,386,000 for the same period in 2024, an increase of 61.4% (*). The GAAP diluted earnings per share were $2.07 and $1.69 for the quarters ending March 31, 2025 and 2024, respectively. Adjusted diluted earnings per share were $1.59 and $0.99 for the quarters ending March 31, 2025 and 2024, respectively (*).
(*) - See the tables below that provide a reconciliation of GAAP to non-GAAP items.
About NHC
NHC affiliates operate for themselves and third parties 80 skilled nursing facilities with 10,329 beds. NHC affiliates also operate 26 assisted living communities with 1,413 units, nine independent living communities with 777 units, three behavioral health hospitals, 34 homecare agencies, and 33 hospice agencies. NHC’s other services include Alzheimer’s and memory care units, pharmacy services, a rehabilitation services company, and providing management and accounting services to third party post-acute operators. Other information about the company can be found on our web site at www.nhccare.com.
Non-GAAP Financial Presentation
The Company is providing certain non-GAAP financial measures as the Company believes that these figures are helpful in allowing investors to more accurately assess the ongoing nature of the Company’s operations and measure the Company’s performance more consistently across periods. Therefore, the Company believes this information is meaningful in addition to the information contained in the GAAP presentation of financial information. The presentation of this additional non-GAAP financial information is not intended to be considered in isolation or as a substitute for the financial information prepared and presented in accordance with GAAP.
Story Continues
Forward-Looking Statements
Statements in this press release that are not historical facts are forward-looking statements. NHC cautions investors that any forward-looking statements made involve risks and uncertainties and are not guarantees of future performance. The risks and uncertainties are detailed from time to time in reports filed by NHC with the S.E.C., including Forms 8-K, 10-Q, and 10-K. All forward-looking statements represent NHC’s best judgment as of the date of this release.
Consolidated Statements of Operations (in thousands, except share and per share amounts) Three Months Ended March 31 2025 2024 (unaudited) Revenues: Net patient revenues $ 361,607 $ 285,823 Other revenues 12,090 11,353 Net operating revenues 373,697 297,176 Costs and expenses: Salaries, wages and benefits 228,130 183,138 Other operating 92,457 77,429 Facility rent 11,365 10,348 Depreciation and amortization 10,978 10,586 Total costs and expenses 342,930 281,501 Income from operations 30,767 15,675 Non-operating income 4,079 5,685 Interest expense (2,106 ) (46 ) Unrealized gains on marketable equity securities 10,982 14,399 Income before income taxes 43,722 35,713 Income tax provision (11,432 ) (9,462 ) Net income 32,290 26,251 Net income attributable to noncontrolling interest (85 ) (38 ) Net income attributable to National HealthCare Corporation $ 32,205 $ 26,213 Net income per common share Basic $ 2.09 $ 1.71 Diluted $ 2.07 $ 1.69 Weighted average common shares outstanding Basic 15,438,306 15,350,240 Diluted 15,575,752 15,505,096 Dividends declared per common share $ 0.61 $ 0.59 Balance Sheet Data March 31 December 31 (in thousands) 2025 2024 (unaudited) Cash, cash equivalents and marketable securities $ 243,171 $ 216,185 Restricted cash, cash equivalents and marketable securities 167,639 163,795 Current assets 455,204 424,408 Property and equipment, net 679,448 684,289 Total assets 1,548,821 1,524,429 Current liabilities, excluding long-term debt due within one year 231,725 227,297 Current and long-term debt 134,000 137,000 NHC stockholders' equity 1,004,895 980,161
Selected Operating Statistics Three Months Ended March 31 2025 2024 (unaudited) Skilled Nursing Per Diems: Medicare $ 612.13 $ 581.75 Managed Care 492.40 470.56 Medicaid 281.67 265.27 Private Pay and Other 337.04 307.84 Average Skilled Nursing Per Diem $ 360.14 $ 343.48 (1) Skilled Nursing Patient Days: Medicare 86,254 81,156 Managed Care 83,646 65,431 Medicaid 363,642 281,821 Private Pay and Other 184,594 157,443 Total Skilled Nursing Patient Days 718,136 585,851 (1) (1) NHC exited three skilled nursing facilities in Missouri on March 1, 2024. For the first quarter of 2024, the exited Missouri skilled nursing facilities had an average skilled nursing per diem of $275.64 and 20,267 patient days. The tables below provide reconciliations of GAAP to non-GAAP items (in thousands, except per share amounts): Three Months Ended March 31 2025 2024 (unaudited) Net income attributable to National Healthcare Corporation $ 32,205 $ 26,213 Non-GAAP adjustments Unrealized gains on marketable equity securities (10,982 ) (14,399 ) Gain on sale of unconsolidated company - (1,025 ) Stock-based compensation expense 1,027 793 Income tax provision on non-GAAP adjustments 2,588 3,804 Non-GAAP Net income $ 24,838 $ 15,386 GAAP diluted earnings per share $ 2.07 $ 1.69 Non-GAAP adjustments Unrealized gains on marketable equity securities (0.71 ) (0.93 ) Gain on sale of unconsolidated company - (0.07 ) Stock-based compensation expense 0.06 0.05 Income tax provision on non-GAAP adjustments 0.17 0.25 Non-GAAP diluted earnings per share $ 1.59 $ 0.99
View source version on businesswire.com: https://www.businesswire.com/news/home/20250509983241/en/
Contacts
Brian F. Kidd, SVP/CFO
(615) 890-2020
View Comments
NHC Reports First Quarter 2025 Earnings
You are reading a free article with opinions that may differ from the recommendation given by Kalkine in its paid research reports. Become a Kalkine member today to get access to our research reports, in-depth technical and fundamental research. Learn more
Start Your Free Trial Now!Download Free Report – Explore 3 Stock Ideas & Industry Insights
Unlock 3 stock ideas and key industry insights in our free report. This information is general in nature and does not consider your personal objectives, financial situation, or needs. It is not financial advice.
All investments involve risk—consider independent advice before making any investment decisions.
View 3 Research ReportsThis information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on ‘as is’ basis, using their API. The information and data provided on this page, as well as via the API, are not guaranteed to be real-time or accurate. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general informational purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine does not assume any responsibility for any trading losses you might incur as a result of using this information, data, or any analyst rating or recommendation provided. Kalkine will not accept any liability for any loss or damage resulting from reliance on the information, including but not limited to data, quotes, charts, analyst ratings, recommendations, and buy/sell signals sourced via the API.
Please be fully informed about the risks and costs associated with trading in the financial markets, as it is one of the riskiest forms of investment. Kalkine does not provide any warranties regarding the information on this page, including, without limitation, warranties of merchantability or fitness for a particular purpose or use.
Please wait processing your request...